
Ameriprise (AMP) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
4.4B
Net Income
583.0M
13.39%
EPS (Diluted)
$5.83
Balance Sheet Metrics
Total Assets
179.1B
Total Liabilities
173.6B
Shareholders Equity
5.4B
Debt to Equity
32.00
Cash Flow Metrics
Operating Cash Flow
1.1B
Free Cash Flow
1.6B
Revenue & Profitability Trend
Ameriprise Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 17.3B | 15.5B | 14.3B | 13.4B | 11.9B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 9.9B | 8.9B | 8.7B | 8.5B | 7.2B |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 9.9B | 8.9B | 8.7B | 8.5B | 7.2B |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 329.0M | 324.0M | 198.0M | 191.0M | 162.0M |
Other Non-Operating Income | 516.0M | 513.0M | 491.0M | 382.0M | 283.0M |
Pre-tax Income | 4.3B | 3.2B | 3.9B | 4.2B | 1.8B |
Income Tax | 866.0M | 678.0M | 782.0M | 768.0M | 297.0M |
Effective Tax Rate % | 20.3% | 21.0% | 19.9% | 18.4% | 16.2% |
Net Income | 3.4B | 2.6B | 3.1B | 3.4B | 1.5B |
Net Margin % | 19.7% | 16.5% | 22.1% | 25.5% | 12.9% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $33.67 | $24.18 | $28.29 | $29.13 | $12.39 |
EPS (Diluted) | $33.05 | $23.71 | $27.70 | $28.48 | $12.20 |
Basic Shares Outstanding | 96166693 | 100173212 | 105278990 | 110861010 | 123800000 |
Diluted Shares Outstanding | 96166693 | 100173212 | 105278990 | 110861010 | 123800000 |
Income Statement Trend
Ameriprise Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 8.5B | 7.6B | 7.1B | 7.2B | 6.8B |
Short-term Investments | 52.2B | 51.6B | 40.8B | 32.0B | 36.3B |
Accounts Receivable | 14.5B | 15.1B | 15.6B | 16.2B | 7.8B |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 181.4B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | - | - | - | - | - |
Short-term Debt | 701.0M | 751.0M | 1.5B | 200.0M | 200.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 4.8B | 5.0B | 3.9B | 5.0B | 4.7B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 176.2B | - | - | - | - |
Equity | |||||
Common Stock | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M |
Retained Earnings | 24.7B | 21.9B | 19.9B | 17.5B | 15.3B |
Treasury Stock | 27.7B | 25.2B | 23.1B | 21.1B | 18.9B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 5.2B | 4.7B | 3.8B | 5.9B | 5.9B |
Key Metrics | |||||
Total Debt | 5.5B | 5.8B | 5.4B | 5.2B | 4.9B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Ameriprise Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 3.4B | 2.6B | 3.1B | 3.4B | 1.5B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 193.0M | 187.0M | 170.0M | 152.0M | 146.0M |
Working Capital Changes | -1.0B | -694.0M | 777.0M | -1.3B | -227.0M |
Operating Cash Flow | 2.7B | 2.1B | 4.3B | 2.4B | 1.2B |
Investing Activities | |||||
Capital Expenditures | -176.0M | -184.0M | -182.0M | -120.0M | -147.0M |
Acquisitions | -8.0M | 216.0M | -312.0M | -1.1B | -351.0M |
Investment Purchases | -18.8B | -19.9B | -22.8B | -15.4B | -14.1B |
Investment Sales | 18.2B | 10.2B | 9.2B | 12.3B | 11.6B |
Investing Cash Flow | -313.0M | -9.1B | -13.5B | -4.4B | -2.9B |
Financing Activities | |||||
Share Repurchases | -2.4B | -2.1B | -2.0B | -2.0B | -1.4B |
Dividends Paid | -574.0M | -550.0M | -534.0M | -511.0M | -497.0M |
Debt Issuance | 1.3B | 1.3B | 836.0M | 1.8B | 878.0M |
Debt Repayment | -1.6B | -1.0B | -514.0M | -1.2B | -836.0M |
Financing Cash Flow | -5.2B | 4.4B | 8.4B | 1.7B | 949.0M |
Free Cash Flow | 6.4B | 4.5B | 4.2B | 3.2B | 4.5B |
Net Change in Cash | -2.8B | -2.7B | -766.0M | -328.0M | -841.0M |
Cash Flow Trend
Ameriprise Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
17.70
Forward P/E
13.48
Price to Book
8.08
Price to Sales
2.70
PEG Ratio
13.48
Profitability Ratios
Profit Margin
17.74%
Operating Margin
36.30%
Return on Equity
58.24%
Return on Assets
2.20%
Financial Health
Current Ratio
9.17
Debt to Equity
53.93
Beta
1.22
Per Share Data
EPS (TTM)
$29.42
Book Value per Share
$64.43
Revenue per Share
$183.87
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
amp | 49.1B | 17.70 | 8.08 | 58.24% | 17.74% | 53.93 |
BlackRock | 175.9B | 27.48 | 3.58 | 13.92% | 29.69% | 28.51 |
Brookfield | 103.4B | 232.59 | 2.46 | 0.95% | 0.73% | 156.81 |
Brookfield Asset | 99.1B | 42.94 | 11.69 | 23.07% | 55.92% | 11.33 |
Raymond James | 33.7B | 16.07 | 2.93 | 18.87% | 16.14% | 36.49 |
State Street | 31.5B | 12.48 | 1.34 | 10.95% | 21.39% | 1.96 |
Financial data is updated regularly. All figures are in the company's reporting currency.